Reticular pseudodrusen and subretinal hyperreflective material are among the OCT findings that may predict macular atrophy in ...

Ruvembri is under clinical development by Biophytis and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.

A multinational study led by the LHON Study Group has revealed sustained visual improvements and a favorable safety profile ...

The drug and biotech sector had a turbulent year in 2024, starting strong but losing momentum in the second half. This ...

According to the MP Board’s date sheet for the 2024-25 session, Class 10 exams will take place in the morning shift from 9:00 ...

Clarity is not rated by Morgans. The retinal-diseases-focused biotech is awaiting two phase III trial results in CY25. The ...

Here's everything you need to know for the 2024 NCAA DIII football championship that features 40 teams battling it out in a single-elimination bracket. The 40-team championship bracket was ...

Bayer announced positive topline results from the global phase III QUASAR study evaluating the efficacy and safety of aflibercept 8 mg in patients with macular edema following retinal vein occlusion ...

Helmed at a breakneck pace by Jeff Fowler, “Sonic the Hedgehog 3” is loud, chaotic and often corny, with a visual style that ...

Regeneron’s phase III QUASAR study evaluated the efficacy ... across patients with branch RVOs and those with central retinal or hemiretinal vein occlusions. In the past three months, shares ...

Regeneron Pharmaceuticals REGN announced that it has met the primary endpoint in a late-stage study evaluating Eylea HD ...